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High Campylobacter prevalence during early childhood has been associated with
stunting and environmental enteric dysfunction (EED), especially in low resource settings.
This study assessed the prevalence, diversity, abundance, and co-occurrence of
Campylobacter spp. in stools from children in a rural area of eastern Ethiopia and their
association with microbiome, diarrhea, and EED in children. Stool samples (n = 100)
were collected from randomly selected children (age range: 360–498 days) in five
kebeles in Haramaya District, Ethiopia. Diarrhea, compromised gut permeability, and gut
inflammation were observed in 48, 45, and 57% of children, respectively. Campylobacter
prevalence and species diversity were assessed using PCR and meta-total RNA
sequencing (MeTRS). The prevalence of Campylobacter spp. in the children’s stools
was 50% (41–60%) by PCR and 88% (80–93.6%) by MeTRS (P < 0.01). Further,
seven Campylobacter species (Campylobacter jejuni, Campylobacter upsaliensis,
Campylobacter hyointestinalis, Campylobacter coli, Campylobacter sp. RM6137,
uncultured Campylobacter sp., and Campylobacter sp. RM12175) were detected
by MeTRS in at least 40% of children stools in high abundance (>1.76-log read
per million per positive stool sample). Four clusters of Campylobacter species (5–12
species per cluster) co-occurred in the stool samples, suggesting that Campylobacter
colonization of children may have occurred through multiple reservoirs or from a reservoir
in which several Campylobacter species may co-inhabit. No associations between
Campylobacter spp., EED, and diarrhea were detected in this cross-sectional study;
however, characteristic microbiome profiles were identified based on the prevalence of
Campylobacter spp., EED severity, and diarrhea. Forty-seven bacterial species were
correlated with Campylobacter, and 13 of them also correlated with gut permeability, gut
inflammation and/or EED severity. Forty-nine species not correlated with Campylobacter
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were correlated with gut permeability, gut inflammation, EED severity and/or diarrhea.
This study demonstrated that (1) in addition to C. jejuni and C. coli, multiple non-
thermophilic Campylobacter spp. (i.e., Campylobacter hyointestinalis, Campylobacter
fetus, and Campylobacter concisus) were frequently detected in the children’s stools and
(2) the Campylobacter, gut permeability, gut inflammation, EED severity, and diarrhea
were associated with characteristic microbiome composition. Additional spatial and
longitudinal studies are needed to identify environmental reservoirs and sources of
infection of children with disparate Campylobacter species and to better define their
associations with EED in low-income countries.
Keywords: Campylobacter, non-thermotolerant Campylobacter, EED, diarrhea, malnutrition, stunting, livestock
reservoirs, MeTRS
INTRODUCTION
Campylobacter species are the most common zoonotic
pathogens and the most frequent bacterial cause of foodborne
disease worldwide (1). Campylobacter infection is frequently
asymptomatic, and clinical cases may present with symptoms
ranging from diarrhea, abdominal pain, and fever to severe
consequences like reactive arthritis and, although rarely
occurring, Guillain–Barré syndrome (2). Among the cases
of diarrhea in children <5 years old, 15% was caused by
Campylobacter infections (3). Warm-blooded animals, and
particularly avian species, are common reservoir hosts for
Campylobacter and infection in animals in most cases is
asymptomatic. Campylobacter transmission from animal
reservoirs to humans may occur through multiple routes,
including contaminated food (especially poultry meat) and
water, the environment, and contact with infected animals (4, 5).
Children can be exposed to Campylobacter spp. directly or
indirectly through exposure to animal feces (6).
Recent studies have also shown association of both
symptomatic and asymptomatic Campylobacter infections
with growth faltering in children from developing countries
(7, 8). Approximately 24 million (35.2%) children under five,
from East Africa were stunted, 4.1 million (6%) were wasted, and
2.9 million (4.3%) were overweight in 2018 (9). High exposure
to enteric pathogens may result in environmental enteric
dysfunction (EED), a subclinical disorder of the small intestine
characterized by villous atrophy, crypt elongation, inflammatory
cells infiltration of the crypts and a loss of barrier function or
increased permeability (10). EED is considered to be involved
in the causal pathway from pathogen exposure to stunting
(11, 12). A study in multi-country settings, Campylobacter spp.
were isolated in both diarrheic and non-diarrheic children in
their first and second year of life (13). In addition to these, the
MAL-ED project revealed a high Campylobacter infection in
children in eight low-resource settings and this was associated
with growth shortfalls, increased intestinal permeability, and
intestinal and systemic inflammation at 24 months of age (7).
In Ethiopia, the rate of stunting among children under
five is alarmingly high (38% in 2016); and a recent study
indicated that the average height-for-age Z-score (HAZ) in
a large sample of Ethiopian children decreased from −0.7
to −2.0 standard deviations between 6 and 18 months of
age (14). In previous studies, high prevalence of thermophilic
Campylobacter spp. in humans and domestic animals have
been documented (15–18). Studies from Gondar, Hawassa and
Jimma, Ethiopia indicated that Campylobacter was a major
cause of diarrhea in children <5 years (15, 16) with high
prevalence of Campylobacter in children who had exposure to
domestic animals mainly chicken (15). Evidence are still lacking
in Ethiopia concerning the association between Campylobacter
spp. and EED in children. Thermotolerant Campylobacter spp.
(i.e., Campylobacter jejuni, Campylobacter coli, Campylobacter
lari, and Campylobacter upsaliensis) are frequent causal agents
of campylobacterioisis. However, infection of children with
non-thermophilic Campylobacter spp. (e.g., Campylobacter
hyointestinalis, Campylobacter fetus, Campylobacter showae,
and Campylobacter concisus) is largely underestimated due to
unsuitable culturing methods and their public health risks
specifically in EED pathogenesis is not known (19, 20).
Improving gut health in children can improve growth and
cognitive development and the efficacy of oral vaccines (21).
The fight against stunting and wasting is the prioritized agenda
of several regional, national and international interventions
in low and middle-income countries (22). Understanding the
causes of EED and specifically characterizing the associated
pathogens provide opportunities to design effective interventions
to improve the health and well-being of children. Therefore,
the current study is aimed at estimating the prevalence,
abundance, diversity, and co-occurrence of Campylobacter spp.
in children stools collected in the Haramaya District/Woreda,
East Hararghe zone, Oromia region, in rural eastern Ethiopia,
and to assess their association with EED, diarrhea, and host
microbiome. This study is a part of the cross-sectional formative
research of the Campylobacter Genomics and Environmental
Enteric Dysfunction (CAGED) project, which included an
epidemiological investigation of Campylobacter exposure, EED,
stunting, and their associated risk factors. Results provided by
this cross-sectional study will provide a strong baseline for
examining the role of Campylobacter in EED.
MATERIALS AND METHODS
Study Area
The study was conducted in five rural kebeles (Biftu
Geda, Damota, Finkile, Gobe Chala, and Negeya;
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smallest administrative unit in Ethiopia) in the Haramaya
District/Woreda, East Hararghe zone of Oromia Regional state,
Eastern Ethiopia (Figure 1). Haramaya District is located about
525 km from Addis Ababa (capital city of Ethiopia). The altitude
of Haramaya District ranges from 1,400 to 2,340 meters above
sea level. Haramaya District has 36 rural kebeles and three urban
kebeles. The national census of 2007 reported a total population
of 271,018 (138,282 men and 132,736 women) (23) for this
District. A survey of the land in Haramaya District shows that
36.1% is arable or cultivable, 2.3% pasture, 1.5% forest, and the
remaining 60.1% is considered built-up, degraded, or otherwise
unusable. The livestock population of the Haramaya District was
estimated as; 111,528 cattle, 69,950 sheep, 106,145 goats, 137,545
chickens, 529 camels, and 31,385 donkeys. Khat, vegetables,
and fruits represent major cash crops of this district (Haramaya
District Agriculture and Livestock office; unpublished data).
Study Design and Sample Size Calculation
A cross-sectional study was conducted on children between
October 2018 to December 2018 (age range: 360–498 days). For
the prevalence estimation, sample size was calculated based on a
binomial distribution. A sample of 100 children allows estimation
of 50% prevalence with a precision of 10% at 95% confidence
interval, and a power of 80%. The target number of 100 children
was distributed over the five kebeles (between 9 and 32 children
per kebeles) based on the number of children in the sampling
frame but rounded to the nearest multiple of 10. Full details of the
enrollment process are described in Chen et al. (under review).
Sample Collection and Transportation
Stool samples were collected weekly from 10 children in one of
the selected kebeles over 3 month period until the desired sample
size (n = 100) was achieved. Child caretakers were invited to
bring the children to the local health post for stool sampling.
The samples were collected in a clean plastic sheet and then
immediately transferred into four FluidXTM 2D-Barcoded 2.0mL
sample storage tubes (Thermo ScientificTM, Waltham, MA, USA)
and kept in an ice box and transferred to the laboratory at
Haramaya University on the same day. Sample ID, date, and time
of collection were verified, and samples were stored at −80◦C
FIGURE 1 | Prevalence of Campylobacter, environmental enteric dysfunction (EED) and diarrhea in children in the five kebeles from Haramaya District (East Ethiopia).
Pie graphs in red (positive for Campylobacter) and blue (negative for Campylobacter) represent the Campylobacter prevalence in stool samples (n = 100) collected
from the designated kebele. Prevalence was determined using conventional PCR (c-PCR) or MeTRS (meta-total RNA sequencing). Pie graphs in green (“normal”),
yellow (“moderate” EED), and orange (“severe” EED) represent the prevalence and severity of the EED for the designated kebele. Additional details concerning the
EED severity determination are presented in Table S1. Pie graphs in brown (child currently having or had diarrhea in the past 15 days), gray (child had no diarrhea in
the past 15 days) represent the diarrheal status of the children. GC, Gobe Chala; NG, Negaya; FK, Finkle; DM, Damota; BG: Biftu Geda.
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until further use for DNA extraction. The child caretaker was
asked whether the child had diarrhea during the 15 days before
collection. Additional details concerning the diarrhea scoring are
described in Chen et al. (under review).
Prevalence and Measurement of EED
Prevalence of EED and its measurements are described in
detail in Chen et al. (under review). EED was determined
by assessing both gut permeability and inflammation. The
lactulose absorption (L%) was measured via sugar absorption
test, as previously described (24), and was used as a maker
to assess the gut permeability of the children. Classification of
EED severity was performed as previously described (25). The
child was considered “normal” if the L% was lower than 0.2;
“moderate” if the L% was between 0.2 and 0.45, and “severe”
if the L% was above 0.45. Myeloperoxidase (MPO) in the stool
samples was measured using a commercially available enzyme
linked immunosorbent assay (MPO RUO, Alpco, Salem, NH)
to assess the gut inflammation. The child was considered having
“normal” gut integrity if the [MPO] was lower than 2,000 ng/ml,
“moderate” gut inflammation if the [MPO] was in between
2,000 and 11,000 ng/ml, and “severe” gut inflammation if the
[MPO] was above 11,000 ng/ml. Due to the lack of correlation
between the abundance of Campylobacter in stool and lactulose
absorption and MPO data (r2 < 0.2; P > 0.05), the EED
severity in the children was estimated by cross-tabulating the
classifications generated for both L% and [MPO] (Figure S1).
Extraction of Genomic DNA
Extraction of the genomic DNA from stool samples was
performed by using PurelinkTM Microbiome DNA purification
kit (Invitrogen, Carlsbad, CA, USA). Traces of RNA were
removed using RNAse treatment (Thermo ScientificTM,
Waltham, MA, USA) as previously described (26, 27). Genomic
DNA was resuspended in 50 µl of nuclease free water (Qiagen,
CA, USA) and stored at −20◦C for further use. Quality and
quantity of the extracted DNA was assessed using 1.5% agarose
gel electrophoresis and Nanodrop 2000C Spectrophotometer
(Thermo ScientificTM, Waltham, MA, USA).
Detection of Campylobacter spp. in child
Stool Samples Using Conventional PCR
Detection of Campylobacter spp. in DNA from stool samples was
performed using multiplex conventional PCR with the GoTaq
Green Master Mix kit (Promega Life Sciences, Madison, WI,
USA). C. jejuni 81–176, C. coli ATCC33559, and sterile water
were used as controls. Campylobacter genus-specific PCR was
performed using 16S RNA primers and Campylobacter species-
specific PCR was performed using ceuE primers for the detection
of C. coli and mapA primers for the detection of C. jejuni
(28). The primers used and the expected PCR product sizes are
described in Table S1. The PCR was performed as described in
Denis et al. (28) in a Mastercycler nexus gradient PCR system
(Eppendorf, Hamburg, Germany). PCR products were visualized
using 1.5% agarose gel (VWR International, Radnor, PA, USA)
under UV light.
RNA Extraction, Library Preparation and
Sequencing
RNA extraction was performed using approximately 0.25 g of
stool sample with the Quick-RNA Fecal/Soil Microbe Microprep
Kit (Zymo Research, CA, USA) according to the manufacturer’s
protocol. Four water samples were used as controls during
extraction and library preparation. RNA concentration was
measured using Qubit (Invitrogen, Carlsbad, CA, USA). Meta-
total RNA sequencing (MeTRS) was used to analyze the
microbiome composition of the children stools based on
previously published work (29). The library generation was
performed with NEBNext R© UltraTM II RNA Library Prep (New
England Biolabs, MA, USA). Sequencing was performed to
obtain ∼400M reads using the Illumina NextSeq (Illumina,
Inc., San Diego, CA, USA) across the 100 stool samples. For
each sample, 25 pg of External RNA Controls Consortium
(ERCC) RNA Spike-In Mix (Life Technologies, Carlsbad, CA,
USA) was added prior to library preparation to determine the
limit of detection for each sample. The average lower limit
of detection was 49 attomoles. The average RNA input per
samples was calculated using the following equation (total input
RNA = ercc_pg/ercc_reads ∗ total_reads) where “ercc_reads”
is the number of reads generated from the water control
and “total_reads” is the number of reads generated from test
RNA including the water control. The average input was
∼66 ng/sample.
Bioinformatic Analysis of the MeTRS Data
MeTRS data analysis was performed using IDseq pipeline version
3.7 available at https://github.com/chanzuckerberg/idseq-web/
wiki (30). The details of the IDseq pipeline used for MeTRS
data analysis is included in the Supplemental Material 1. Only
identified organisms with at least 10 reads, an alignment length
above 50 bp, and a Z-score above 1 were considered for the
statistical analyses.
Statistical Analysis
MeTRS abundance data (reads per million; rpm) were log
transformed. Statistical analyses were performed using JMP PRO
14 software (SAS Institute, Cary, NC, USA). The homogeneity
of the MeTRS data for each child was analyzed using a principal
component analysis (PCA) combined with restricted maximum
likelihood (REML) estimation and T2 statistic test (square of
the Mahalanobis distance). Similarity in the Campylobacter
spp. profiles between children obtained with the MeTRS data
was determined using hierarchical clustering. Discriminant
analyses were performed to identify specific members of the
microbial species responsible for the variability observed in
the PCA and clustering data based on the designated nominal
parameter used (kebeles, presence/absence of Campylobacter,
EED severity, and diarrhea status). The percentage of stool
samples clustering within their own group (confidence interval
of 95%; CI 95%) was used to determine whether the designated
nominal parameters explained the variability observed between
stool samples. A Wilcoxon test was performed to identify rpm
abundance differences for a given member of the microbial
species based on a specific nominal parameter. Correlations
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TABLE 1 | Prevalence of Campylobacter, Campylobacter jejuni, and
Campylobacter coli in child stools using conventional PCR and MeTRS
approaches.
Taxonomic
group
Conventional PCR MeTRS*
Positive
samples
Prevalence
(%)
Positive
samples
Prevalence
(%)
Campylobacter
genus
51 50 (40-61) 88 88
(80–93.6)
C. jejuni 13 13 (7-21) 37 37 (27-46)
C. coli 2 2 (0.2–7) 24 24 (17-32)
*samples were considered positive for Campylobacter spp. if at least 10 reads per sample
of at least 50 bp long were mapped to reference genome with a Z-score higher than 1.
between the MeTRS, EED severity, and diarrhea data were
performed using a multivariate analysis combined with Pearson
product-moment correlation coefficient. The co-occurrence of
the Campylobacter spp. was studied using Cluster and Factoextra
R packages (SAS Institute, Cary, NC, USA) on the K-means
clustering data extracted from the multivariate analysis data
(r2) obtained with the Campylopbacter spp. prevalence data.
The optimization of the number of clusters for the PCA was
performed using the Silhouette method. The abundance of
each bacteria in the stool samples was estimated using MeTRS
approach, which is based on RNA read quantification; therefore,
we do not exclude the possibility that this approach over or under
estimates the quantitative data (reads per million) described in
this study.
Data Accession
MeTRS raw reads have been deposited in the IDseq platform
(https://idseq.net) in accordance with the Chan Zuckerberg
Biohub and Chan Zuckerberg Initiative (CZI).
RESULTS
Prevalence of Campylobacter spp. in child
Stool Using Conventional PCR
The genus-specific PCR analysis showed that 50% (40–60%,
95% CI) of the child stools (n = 100) were positive for the
Campylobacter genus across the five kebeles (Table 1); however,
the Campylobacter prevalence significantly differed between
kebeles (P < 0.05; Figure 1 and Figure S2A). The prevalence
was higher in Negeya (84.4%) compared to Biftu Geda (55.2%),
followed by Finkile (33.3%), Damota (18.2%) and Gobe Chala
(15.8%; Figure 1 and Figure S2A).
The species-specific PCR analysis showed that 13% (7–21%)
of children were colonized with C. jejuni and only 2% (0.2–7%)
with C. coli (Table 1). The prevalence of children positive for C.
jejuni and C. coli did not differ between kebeles (Figure S2A).
These results suggested that large proportion of Campylobacter
in children stools likely represent other Campylobacter species,
possibly including non-thermotolerant Campylobacter.
Prevalence of Campylobacter spp. in child
Stools Using Meta-Total RNA Sequencing
In order to identify the full spectrum of Campylobacter
species present in the stool samples, MeTRS was performed
on 100 children stool samples. The MeTRS analysis showed
that Campylobacter was detected in 88% (95% CI: 80–94%)
of the children’s stools (Table 1). A total of 27 classified
Campylobacter species and 12 unclassifiedCampylobacter species
were detected among the 88 Campylobacter positive stools
based on the annotation in the NCBI database with average
sequence identity of 97% for each species (https://www.ncbi.nlm.
nih.gov/Taxonomy/Browser/wwwtax.cgi; Figure 2). An average
of 11 Campylobacter spp. was detected per Campylobacter
positive stool. Seven Campylobacter spp. (from highest to lowest
prevalence; Campylobacter sp. RM12175, C. hyointestinalis, C.
jejuni, Campylobacter sp. RM6137, uncultured Campylobacter
sp., C. upsaliensis, and C. coli) were detected in at least 40%
of the stools at high abundance (at least 1.76-log rpm per
positive stool; Figure 2); and seven other Campylobacter spp.
(Campylobacter sp. NCTC 13003, Campylobacter helveticus,
Campylobacter lanienae, C. concisus, C. fetus, Campylobacter
pinnipediorum, and C. showae) were detected in at least 40% of
the stools but at lower abundance (between 0.95-log and 1.76-log
rpm per positive stool; Figure 2).
Further, based on the prevalence data (Figure 2), it was also
observed that specific Campylobacter spp. often co-occurred in
the children stools (Figure 3 and Figure S3). A total of four
clusters of co-occurrences (n = 5–12 Campylobacter spp. per
cluster) were detected. The green cluster (C. coli, C. jejuni, C.
helveticus, C. upsaliensis C. iguaniorum, and C. lari) and the
red cluster (C. gracillis, C. sp. RM12175, C. sputorum, and C.
ureolyticus, C. hyointestinalis, C. curvus, C. fetus, C. lanienae,
C. pinnipediorum, Campylobacter sp. RM6137, Campylobacter
sp. RM12175, C. showae, and uncultured Campylobacter sp.)
displayed higher co-occurrence similarities compared to the blue
cluster (C. rectus, C. subantarcticus, C. hepaticus, C. hominis,
C. concisus, C. canadensis, and C. pelondis) and the violet
cluster (C. avium, C. cuniculorum, C. insulaenigrae, C. volucris,
and C. troglodytis), respectively based on dimension 1, which
explained 44.4% variability between the cluster. Interestingly, the
green cluster was mostly composed of the five most commonly
reported thermotolerant Campylobacter species (C. coli, C.
jejuni, C. helveticus, C. upsaliensis, and C. lari), while the red
cluster consisted of non-thermotolerant Campylobacter species
(C. hyointestinalis, C. fetus, and C. showae).
Unlike the PCR data, the distribution of the Campylobacter
positive children stools (at the genus and species level), and
the prevalence of the Campylobacter species in the stools
were overall independent of the kebeles (P > 0.05; Figure 2,
Figures S4A,B). Approximately 65% (45–84%) of the stool
samples clustered within their own kebeles based on the
abundance of the Campylobacter spp. detected in the stool
samples (Figure S4C). Therefore, due to the high variability
observed within most of the kebeles (4/5), the five kebeles were
pooled into one (n = 100) to enhance the veracity of the
MeTRS data described below. Only the abundance (read per
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FIGURE 2 | Campylobacter spp. prevalence, diversity, and abundance in
children stools. A total of 27 classified Campylobacter spp. and 12
unclassified Campylobacter spp. were detected in the 100 child stool samples
collected from children in the five kebeles using MeTRS. (A) Campylobacter
spp. prevalence and diversity in the stool samples. Blue and red cells
represent the absence or presence of Campylobacter spp. in the designated
stool samples (cut-off; contigs number ≥ 10; Read length ≥ 50; Z-score ≥ 1).
Kebeles with the same color code belong to the same cluster and therefore
harbored equivalent Campylobacter sp. diversity. (B) Abundance of
Campylobacter spp. in the positive stools. White bar represents
Campylobacter spp. with a prevalence lower than 40% and an abundance
lower than 0.95-log rpm per stool sample. Gray bar represents Campylobacter
spp. with a prevalence higher than 40% and an abundance lower than
1.76-log rpm per stool sample. Black bar represents Campylobacter spp. with
a prevalence higher than 40% and an abundance higher than 1.76-log rpm
per stool sample. rpm: read per million.
million) of C. hyointestinalis and Campylobacter sp. RM12175
significantly differed between kebeles (P < 0.01; Figure S5).
Finkle harbored significantly higher level of C. hyointestinalis
in the stools compared to Gobe Chala, Negeya, and Biftu Geda
(Figure S5A); and Damota harbored significantly higher level of
Campylobacter sp. RM12175 in the stools compared to the other
four kebeles (Figure S5B).
Overall, the percentage of Campylobacter positive stools was
significantly higher using the MeTRS approach compared to
the conventional PCR approach (P < 0.01; Figures S2A,S2B).
Further, some discrepancies were observed between the two
methods used (Figure S2C). Out of the 88 stools positive
for Campylobacter via MeTRS, 42 of them (48%) were also
identified positive via conventional PCR (16S genus-specific
primers); however, five of the 50 (10%) stools positive for the
Campylobacter genus via conventional PCR were not positive for
the Campylobacter via MeTRS analysis (Figure S2C). Similarly,
based on the species-specific PCR (ceuE and mapA primers), six
of 13 (46%) and two of two (100%) stools were positive for C.
jejuni and C. coli, respectively only by PCR but not with MeTRS
(Figure S2C).
The Campylobacter in the Stools Was Not
Associated With Diarrhea and EED Severity
To determine the role of Campylobacter in EED, the levels of
lactulose and MPO were measured as indicators of EED (24,
25). Additional details concerning the prevalence of EED and
stunting among children in this study are described in Chen
et al. (under review).
Out of the 100 children studied, 55 children possessed
“normal” gut permeability (L% below 0.2), 29 children possessed
“moderate” defect in gut permeability (L% between 0.2 and 0.45),
and 16 children possessed “severe” defect in gut permeability
(L% ratio above 0.45). No correlations were identified when
a multivariate analysis was performed between L% and the
prevalence or the abundance of Campylobacter detected in the
children stools (P > 0.05). On the other hand, the discriminant
analysis showed that the overall Campylobacter spp. composition
in the stool differed between the L% status (“normal,” “moderate,”
and “severe”; r2 = 0.37; Figure S6A). Eighty two percent (45/55)
of the children identified as “normal” clustered together based on
the Campylobacter composition in the stool. Besides, only 66%
(19/29) and 44% (7/16) of the child identified as with “moderate”
and “severe” permeability defect, respectively clustered within
their own group based on the Campylobacter composition in
the stool (Figure S6B). Further, 28% (8/29) and 41% (7/17)
of the children identified as with “moderate” and “severe”
permeability defect clustered with the children identified as
“normal.” Overall, the Campylobacter composition in the stool
samples was associated with 58% of the children with “moderate”
and “severe” gut permeability defect based on the L% data.
Similarly, based on the MPO levels, out of the 100
children studied, 43 children possessed “normal” gut ([MPO]
below 2,000 ng/ml), 32 children possessed “moderate” gut
inflammation ([MPO] between 2,000 and 11,000), and 25
children possessed “severe” gut inflammation ([MPO] above
11,000). No correlations were identified when a multivariate
analysis was performed between [MPO] and the prevalence
or the abundance of Campylobacter detected in the children
stools (P > 0.05); however, the Campylobacter spp. composition
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FIGURE 3 | Co-occurrence of Campylobacter spp. in the children stool samples. Co-occurrence profiles were created using K-means clustering data extracted from
the multivariate analysis data (r2) based on the prevalence of Campylobacter spp. in the stool samples (see Figure 2). Additional details regarding the multivariate data
are displayed in Figure S3.
in the stool differed between the inflammation status (r2 =
0.37; Figure S6C). Fifty eight percent (25/43), 88% (28/32) and
48% (12/25) of the children with inflammation status “normal,”
“moderate,” and “severe,” respectively clustered within their own
group based on the Campylobacter composition in the stool
(Figure S6D). Only 9% (3/32) and 8% (2/25) of the children
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identified as having “moderate” and “severe” gut inflammation
clustered with the children identified as “normal.” Overall, the
Campylobacter composition in the stool was associated with 70%
of the children with “moderate” and “severe” gut inflammation
based on the MPO data.
Because of the lack of correlation between the Campylobacter
and the L% and MPO, both parameters were combined together
to build an index estimating the EED (Figure S1). Out of the
100 children studied, 50 children were classified as “normal,”
33 children having “moderate” EED, and 25 children having
“severe” EED (Figure 1). As observed above, the Campylobacter
spp. composition in the stool differed between the EED status (r2
= 0.38; Figure S6E). Ninety percent (45/50), 61% (20/33), and
53% (9/17) of the children identified as “normal,” “moderate,”
and “severe,” respectively clustered within their own group based
on the Campylobacter composition in the stool (Figure S6F).
Overall, the Campylobacter composition in the stool was
associated with 58% of the children with “moderate” and “severe”
EED based on the EED status data.
In addition, the prevalence of child with diarrhea was
recorded to determine the associations with Campylobacter spp.
prevalence and abundance in the stool samples. Additional
details concerning the diarrhea data are described in Chen
et al. (under review). Out of the 100 children studied, 48% of
the children had diarrhea on the day of the stool collection
or 15 days before stool collection (Figure 1). No correlations
were identified when a multivariate analysis was performed
between the diarrhea data and the prevalence or abundance of
Campylobacter spp. in the stool samples (P > 0.05). However,
the discriminant analysis showed that overall the Campylobacter
spp. composition in the stool differed based on the diarrhea
status of the children (r2 = 0.32; Figure S6G). Eighty-one percent
(39/48) of the children with diarrhea clustered together based
on the Campylobacter composition in the stool samples, while
58% (30/52) of the children without diarrhea clustered together
as a separate cluster based on the Campylobacter composition in
stool (Figure S6H).
Specific Bacteria of the Stool Microbiome
Correlated With the Campylobacter
Prevalence and EED Severity
Post-filtering, the MeTRS identified a total of 2,353 bacteria,
642 Archaea, 17 virus/viroid, and 249 eukaryotes at the
species level among the 100 children stool samples studied.
The global analysis of the fecal microbiota revealed that the
majority of children (n = 89) harbored similar microbiota
profile (P < 0.01; Figure S7A). Between 68% and 84% of the
stool samples clustered by kebeles based on the microbiota
composition (Figure S7B). None of the stool samples from
Damota and Biftu Geda displayed microbiome composition
similarities to Finkle stool samples (Figures S7B,S7C), despite
the fact that Finkle is geographically closer to Damota and
Biftu Geda compared to the other kebeles (Figure 1). Further,
19 stools samples displayed higher microbiome composition
similarities with Biftu Geda or Negeya stool samples compared
to the original kebeles (Figures S7B,S7C), independently of the
distance between the kebeles (Figure 1). Given the discriminant
analysis showed that the ellipses (CI 95%) of most kebeles
(4/5) were overlapping, the MeTRS data were analyzed as
one population (n = 100). No distinct correlation was
detected between the Campylobacter species and the virus/viroid
and eukaryotes (P > 0.05, r2 < 0.25); by consequence,
the majority of the results described below focused on
the interconnections between Campylobacter spp. and stool
bacterial community.
Our analysis showed that the bacterial composition in
the stool samples was related to the overall presence of
Campylobacter spp. (Figure S8A). Ninety-four percent (83/94)
of the children stools positive for Campylobacter spp. clustered
together based on their microbiome composition (Figure S8B).
Only 58% (7/12) of the child stools negative for Campylobacter
spp. clustered together in a separate cluster based on their
microbiome composition. Approximately 16.9% of the bacteria
identified in stool samples (n = 387/2,353) were positively
or negatively correlated with the prevalence or abundance of
Campylobacter in the stool samples (r2 > 0.2 or r2 < −0.20;
P < 0.05). Among the bacteria correlated with Campylobacter,
several of them belonged to Arcobacter, Bacillus, Bacteroides,
Bifidobacterium, Capnocytophaga, Clostridium, Collinsella,
Corynebacterium, Enterobacter, Enterococcus, Helicobacter,
Lactobacillus, Olsenella, Paenibacillus, Pantoea, Prevotella,
Serratia, Streptococcus, and Veilonella.
However, out of the 387 species mentioned above only 47 were
correlated (25 negatively and 22 positively) with the prevalence
or abundance of Campylobacter in the stool samples (r2 > 0.2
or r2 < −0.2; P < 0.05) and detected in at least 25 children stool
samples (average of 60 children; Figure 4).Olsenella,Clostridium,
and Streptococcus were the most represented genus in this subset.
Anaerotignum propionicum (r2 = 0.53), Clostridium butyricum
(r2 = 0.47), Hydrogenophilus islandicus (r2 = 0.46) displayed
the highest positive correlation with Campylobacter abundance
in the stool samples; while Burkholderiales bacterium GJ-E10
(r2 =−0.36), Pasteurellaceae bacterium NI1060 (r2 = −0.35),
and Clostridium baratii (r2 = −0.38), displayed the highest
negative correlation with Campylobacter abundance and/or
prevalence in the stool samples.
Only Prevotella dentallis (2.63-log rpm per positive stool
sample) was negatively correlated with both the Campylobacter
abundance and/or prevalence in the stool samples (r2 = −0.2)
and the [MPO] (r2 = −0.22). On the other hand, Butyrate-
producing bacterium SS3/4, [Clostridium] clostridioforme, and
Streptococcus australis were positively correlated with both the
Campylobacter abundance and/or prevalence in the stool (r2 >
0.2) and at least with one of the following parameters ([MPO],
lactulose%, and/or EED severity; r2 > 0.21). Anaerobiospirillum
succiniciproducens, Coriobacterium glomerans, Escherichia coli,
Megamonas hypermegale, Olsenella sp. oral taxon 807, Olsenella
umbonata, and Pediococcus pentosaceus were negatively
correlated with the Campylobacter abundance and/or prevalence
in the stool (r2 <-0.2) but positively correlated with at least one
of the following parameters ([MPO], lactulose%, and/or EED
severity; r2 > 0.23). Only Bifidobacterium kashiwanohense was
positively correlated with the Campylobacter abundance and/or
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FIGURE 4 | Associations between Campylobacter, gut permeability, gut inflammation, environmental enteric dysfunction (EED), diarrhea, and child stool microbiome.
A total of 47 bacterial species positively or negatively correlated (red or blue cells, respectively) with Campylobacter prevalence and abundance (reads per million, rpm;
r2 > 0.20 or r2 < −0.20; P < 0.05), gut permeability (lactulose %), [MPO] in ng/ml, EED status (“normal,” “moderate” EED, “severe” EED), and/or the diarrhea
prevalence data. Additional details concerning the EED severity determination are presented in Table S1. The phylogenetic tree was built using NCBI website (https://
www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi). N: number of stools positive for the designated bacterial species. The bar graph represents the
average abundance (log rpm per positive stool sample) for the selected bacterial species. rpm, read per million; MPO, myeloperoxidase.
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prevalence in the stool (r2 > 0.21) and negatively correlated with
[MPO] (r2 <−0.2).
No bacteria correlated with Campylobacter spp. were
correlated with the presence or absence of diarrhea.
Specific Bacteria of the Stool Microbiome
Correlated With the Gut Permeability, Gut
Inflammation, EED Severity, and Diarrhea
in Children
The microbiome composition was related to the gut permeability
(L%), gut inflammation (MPO), and EED status (Figure S9B),
as observed with the Campylobacter composition in the stool
samples (Figure S6); however, higher correlations between the
L%, EED status and the microbiome composition were observed
compared to the correlation obtained with Campylobacter. Out
of the 100 children studied, 80% (44/55), 79% (23/29), and 81%
(13/16) of the children identified as “normal,” “moderate,” and
“severe” based on the L%, respectively, clustered within their own
group based on themicrobiome composition (Figures S9A,S9B).
Eighty one percent (35/43), 72% (23/32), and 68% (17/25) of
the children identified as “normal,” “moderate,” and “severe”
based on MPO levels, respectively, clustered within their own
group based on the microbiome composition in the stool
(Figures S9C,S9D). Eighty percent (40/50), 79% (26/33), and
76% (13/17) of the children identified as “normal,” “moderate,”
and “severe” based on the EED status (both L% and MPO
combined; Table S1), respectively, clustered within their own
group based on the microbiome composition in the stool
(Figures S9E,S9F). Overall, the microbiome composition was
associated with 80% of the gut permeability data, 70% of
the gut inflammation data, and 78% of the EED severity
data observed in the children with “moderate” and “severe”
status. Similarly, children with diarrhea displayed different
microbiome composition compared to children with no diarrhea
(Figure S9G). Out of the 100 children, 81% (42/52) of the
stools from children with no diarrhea and 85% (41/48) of
the stools from children with diarrhea clustered to their
respective groups based on the microbiome composition
(Figure S9H).
A total of 49 bacteria not-associated with Campylobacter were
correlated (30 positively [r2 > 0.21; P < 0.05] and 19 negatively
[r2 < −0.20; P < 0.05]) with the L%, MPO levels, and/or the
EED severity and detected in at least 25 children stool samples
(Figure S9I). Only Neisseria elongata was positively correlated
with the EED severity (r2 = 0.31; 2.2-fold increased between
the “normal” children and the children with “severe” EED)
and also L% (lactulose%; r2 = 0.21; 1.7-fold increased between
the children with “normal” and “severe” gut permeability).
Eight bacteria (Lachnoclostridium sp. YL32, [Clostridium]
bolteae, Bifidobacterium bifidum, Mordavella sp. Marseille-
P3756, Bacteroides thetaiotaomicron, Streptococcus salivarius,
and Libanicoccus massiliensis) highly prevalent (>71%) and
abundant (>2.0-log rpm per stool sample in children with
“severe” status) in the stools were positively correlated (r2
between 0.24 and 0.36) with L% or MPO levels. On the other
hand, Lactobacillus mucosae and Pasteurella multocida were less
prevalent (39 and 60%, respectively) and less abundant (below
1.0 and 1.5-log rpm per stool, respectively) in the stools, but they
were higher (2.5- and 2-fold, respectively) in the children with
“severe” gut inflammation compared to the “normal” children.
Five bacteria (Mogibacterium diversum, Ethanoligenens
harbinense, Roseburia hominis, Ruminococcus sp. SR1/5, and
Bacteroides dorei) were negatively correlated with the EED
severity (r2 between −0.21 and −0.27) and detected in at least
40% of the children stools (Figure S9I). Interestingly, only
M. diversum was negatively correlated with all the parameters
studied (EED severity [r2 = −0.27], L% [r2 = −0.20], MPO
[r2 = −0.26], and diarrhea prevalence [r2 = −0.25]). Further,
M. diversum abundance in stools was higher in the “normal”
children compared to the children with “severe” EED (2.7-fold),
with “severe” L% (4-fold), and with diarrhea (2-fold). Similarly,
E. harbinense was higher (2.3-fold) in the stools of “normal”
children compared to the children with “severe” EED. Four
bacteria (Clostridium taeniosporum, Hungatella hathewayi,
Selenomonas ruminantium, and Cryotobacterium curtum) were
less prevalent (between 40% and 58%) and abundant (<1.3-log
rpm per stool) in the stools, but they were detected at higher
level (2.2-, 2-, 2.6-, and 2-fold, respectively) in the stools of
“normal” children compared to the children with “severe” MPO.
Further, Selenomonas ruminantium was also detected at higher
level (2-fold) in children with no diarrhea compared to the ones
with diarrhea.
Three additional bacteria (Prevotella scopos, S. ruminantium,
and Measphaera els) highly prevalent (>79%) and abundant
(>2.1-log rpm per stool) in the stools and not-associated with
Campylobacter were negatively correlated (r2 between −0.2 and
−0.22) with the diarrhea data (Figure S9I).
DISCUSSION
The purpose of this study was to estimate the prevalence,
diversity, abundance and co-occurrence of Campylobacter in
the stool of young children from Eastern Ethiopia and assess
potential associations between Campylobacter and diarrhea and
EED (31). To accomplish this task, the use of traditional
microbiology approaches to isolate thermophilic Campylobacter
spp. was attempted; however, due to technical and logistical
challenges faced in Ethiopia, the results generated were
deemed unreliable (data not shown). The fastidious nature
of Campylobacter and difficulty of isolation, rendered culture
and isolation unreliable for estimation of prevalence (32). By
consequence, other studies utilized different approaches to
estimate the prevalence of Campylobacter in stool samples,
including enzyme immunoassay (EIA), PCR, and shotgun
metagenomics (7, 33, 34). Two different culture independent
approaches (conventional PCR and MeTRS) were used in this
study to estimate the prevalence of Campylobacter in the child
stool samples.
The number of child stools detected positive for the
Campylobacter genus was significantly higher using the MeTRS
approach (88% [80–93.6%]) compared to the genus-specific PCR
approach (50% [40–61%]; 16S RNA primer). Several studies
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showed that shotgun metagenomics and MeTRS had at least
equal sensitivity to real-time PCR based approach for different
pathogens (29, 35–37). Further, discrepancies between the two
detection methods was observed, especially with the species-
specific PCR approach (ceuE primer for C. coli and mapA
primer for C. jejuni). However, the reason for this discrepancy
is unknown and needs further investigation. Many factors could
affect the sensitivity of both PCR and MeTRS approaches,
including the type of the sample, the quality and quantity of the
extracted DNA, the agreement between themethod used, the type
of the organism under investigation, and the tools used to analyze
the data. A recent study suggested that shotgun metagenomics
might overestimate the prevalence of microbial population due to
the presence of plasmid sequences within the assembled genome
and the high sequences similarities between bacterial species (38).
In our study, by taking an approach of sequencing the total RNA
component, we are able to better identify species rather than by
sequencing DNA alone. However, the genome coverage obtained
with the MeTRS approach was not high enough to provide
information about strain relatedness within the same species.
Therefore, metagenomic studies using long read technologies or
whole genome sequencing of pure isolates are still needed for
source attribution purposes.
It is commonly known that C. jejuni and C. coli are
leading causes of campylobacteriosis in the western world (39);
however, our study revealed that most of the children stools
positive for Campylobacter (94%) harbored more than one
Campylobacter species. This finding suggests that Campylobacter
colonization of children may have occurred through multiple
reservoirs or from a reservoir in which several Campylobacter
species may co-inhabit. This hypothesis is supported by the
existing literature which describes colonization of multiple
hosts by a given Campylobacter species; for example, C.
hyointestinalis is commonly found in swine, sheep, dog, and in
cattle (40). Further, twelve Campylobacter spp. (Campylobacter
sp. RM12175, C. hyointestinalis, Campylobacter sp. RM6137,
uncultured Campylobacter sp., C. upsaliensis, Campylobacter sp.
NCTC 13003, C. helveticus, C. lanienae, C. concisus, C. fetus, C.
pinnipediorum, and C. showae) in addition to C. jejuni and C. coli
were detected in at least 40% of the stool samples at relatively high
abundance. Our study also showed that several Campylobacter
species were commonly co-occurring within the same stool
samples, while others had opposite trends. However, none of the
clusters representing different Campylobacter species (Figure 3)
were correlated with the gut permeability, gut inflammation, EED
severity, and diarrhea (data not shown). These facts raise many
questions about the mechanisms underlying the Campylobacter
species diversity observed and their potential effect on gut
health and children’s growth. A possible contributor to this
diversity could be the diverse environment surrounding these
children. A previous study demonstrated significant associations
between Campylobacter isolated from children (under 5 years
of age) and the exposure to domestic animal (pets, chickens,
and pigeons) in Gondar, North Western Ethiopia (15). It was
estimated that approximately 83% of the rural households
in Ethiopia possess livestock (cattle, goat, and sheep and
chicken) (23). Further, most of these Campylobacter species
mentioned above (except Campylobacter sp. RM6137) were
reported in livestock such as cattle, sheep, and goat (41).
Therefore, livestock most likely plays a major role as reservoir
and in the horizontal transmission of Campylobacter to children
in Ethiopia. Hence, concurrently studying the prevalence
and diversity of Campylobacter in livestock and children
would provide key information concerning the horizontal
transmission of Campylobacter between livestock and children.
It is also important to notice that four of the most prevalent
Campylobacter species (C. hyointestinalis, C. helveticus, C. fetus,
and C. upsaliensis) detected in the children stools in this study
have not been commonly reported in previous studies, compared
to other species such as C. jejuni, C. coli, C. fetus, C. showae,
and C. concisus, which have been associated with human disease
(41, 42). The reservoirs of non-thermotolerant Campylobacters
are very diverse and not well-understood especially in low to
middle income countries.
Among all the Campylobacter species detected in our study
(27 classified species and 12 unclassified species), the non-
thermotolerant C. hyointestinalis was the second most abundant
and the third most prevalent Campylobacter species in the
children stools. C. hyointestinalis was previously isolated from
numerous livestock species such as swine (43), cattle (43–48),
sheep (43). However, its implication in human diseases is rare
and sporadic (49–53). C. hyointestinalis has also been reported
in developed countries, more precisely in feces collected from
dairy farms in Canada (19.3%), in Finland (10.8%) and from
dairy goat farms in New Zealand (2%), and in 3.2% milk
samples collected from dairy farms in Italy (45, 47, 48, 54). C.
hyointestinalis, as well as, other Campylobacter species were also
isolated from wild boar in Japan and dogs in Canada (55, 56). By
consequence, studying the prevalence, diversity, and abundance
of Campylobacter species in livestock, also in domestic- and wild
animals that have a high likelihood of interacting with livestock
or humans is essential to understand the transmission dynamics
of Campylobacter to children.
Overall, the MeTRS data showed that the microbial
population in the stools in different kebeles was homogeneous
between the children. No correlations between Campylobacter
spp. and gut permeability, gut inflammation, EED severity,
or diarrhea status were observed in our study; however,
characteristic stool microbiome composition profiles
were detected based on the prevalence and abundance
of Campylobacter spp. in the stools, gut permeability, gut
inflammation, EED severity, and diarrhea status. Up to 0.9%
(n = 22 bacterial species) of the microbiome was positively
correlated (r2 > 0.20) and 1.1% (n = 25 bacterial species) was
negatively correlated (r2 < −0.21) with the prevalence and/or
abundance of Campylobacter spp. in the stools. Among them,
only Prevotella dentaliswas highly prevalent (88%) and abundant
(2.63-log rpm per stool) in the stools, and negatively correlated
with both Campylobacter prevalence (r2 = −0.2) and the gut
inflammation (r2 = −0.21). Prevotella is associated with plant-
rich diets and also promotes chronic inflammation (57, 58).
Prevotella is known to provide key nutrients to other bacteria
of the human microbiota and may act on the pathogenicity of
specific pathobionts (59–63); however, no studies demonstrated
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yet potential antagonistic interactions between P. dentalis
and Campylobacter.
Bifidobacterium kashiwanohense was highly prevalent (99%)
and abundant (3.84-log rpm per stool) in the stools and was also
negatively correlated with gut inflammation (r2 = −0.2). This
bacterium possesses high iron sequestration properties andmight
produce indole-3-lactic acids, which was shown to be a successful
strategy to inhibit and compete with enteric pathogens (i.e.,
Salmonella and E. coli) (64, 65). However, B. kashiwanohense was
also positively correlated (r2 = 0.21) with Campylobacter in our
study, suggesting that the modulation of B. kashiwanohense may
reduce the impact of pathobiont on the intestinal homeostasis
but facilitates the persistence of Campylobacter in the child
intestinal tract. On the other hand, Bifidobacterium longum
was negatively correlated with Campylobacter in our study,
which concords with previous published studies (66). Similarly,
other bacteria (Gordonibacter urolithinfaciens, Mogibacterium
pumilum, Megasphaera stantonii, E. coli, Clostridium spp.,
Olsenella spp., and Bacteroides fragilis) were negatively correlated
with Campylobacter in the stools. Several studies showed that
Bacteroides, Gordonibacter, and Escherichia produce molecules
with antimicrobial and anti-inflammatory properties (lactic
acids, short chain fatty acids, enterocins, and urolithins), which
could modulate the microbiome quality, intestinal homeostasis,
and host immune responses and could be effective against
Campylobacter (67–74). Interestingly, several Olsenella spp. (n
= 5) were frequently detected in the stool samples and were
negatively correlated with Campylobacter prevalence. Olsenella
was previously identified as a part of the microbiome associated
with the infant health status (stunting, autism spectrum disorder,
and chronic malnutrition) in China and Bangladesh (75–77).
Therefore, the anti-Campylobacter properties of several species
identified in this study and their potential application as dietary
supplement to control Campylobacter in developing countries
needs further investigation.
Interestingly, M. diversum was the only bacteria of the stool
microbiome with a distinct positive effect on the child gut
permeability (r2 = −0.2), gut inflammation (r2 = −0.26), EED
severity (r2 = −0.27), and diarrhea prevalence (r2 = −0.24), but
no association with Campylobacter. No information is available
concerning this bacterium. Therefore, further investigations are
required to support the beneficial properties of M. diversum
against EED and their potential application as dietary supplement
in developing countries to improve intestinal homeostasis.
On the other hand, the abundance of four bacterial species
(butyrate-producing bacterium SS3/4, Megamonas hypermegale,
Streptococcus australis, and Gordonibacter massiliensis) were
positively correlated with the abundance of Campylobacter in
the stools and with the severity of the gut inflammation, gut
permeability and/or EED severity; Therefore, these bacteria
might have an important impact on the gut microbiome
quality, the persistence of Campylobacter in the gut, and the
children’s health.
In conclusion, we report in this study high prevalence
and diversity of Campylobacter spp. in children in eastern
Ethiopia, including the non-thermophilic Campylobacter spp.
(i.e., C. hyointestinalis and C. fetus-like species). The MeTRS
revealed co-occurrence of several Campylobacter spp. More
studies are needed to better understand the prevalence, sources,
and transmission dynamics of Campylobacter to children
as well as to establish a clear link between Campylobacter
infection (including non-thermotolerant species) in children
with EED and stunting. Furthermore, even though no direct
correlation was identified between Campylobacter prevalence
and abundance, and the EED severity or the diarrhea, the
metagenomic analysis highlighted the association between stool
microbiome and the prevalence and abundance ofCampylobacter
spp., EED severity, and diarrhea in children. The unique changes
in microbiome may serve as biomarkers for disease status
and can help to elucidate the complex interactions between
Campylobacter, the gut microbiome, EED and stunting in the
context of the socio-economic environment of children in
rural Ethiopia.
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Figure S1 | Estimation of environmental enteric dysfunction severity based on gut
permeability and gut inflammation data. The gut permeability was assessed using
the percentage of lactulose in the urine. The gut inflammation was assessed
based on the concentration in MPO (ng/ml) in the urine. Both parameters were
used to estimate the environmental enteric dysfunction (EED) severity for each
infant. The gut inflammation was considered normal if [MPO] was lower than
2,000 ng/ml, moderated if [MPO] was between 2,000 and 11,000 ng/ml, and
severe if [MPO] was higher than 11,000 ng/ml. The gut permeability was
considered normal if the lactulose value was lower than 0.2%, moderated if the
lactulose value was between 0.2 and 0.45%, and severe if the lactulose value was
higher than 0.45%; MPO, myeloperoxidase.
Figure S2 | Campylobacter spp. prevalence in the children stools (n = 100)
collected from five kebeles using conventional PCR (A) and MeTRS (B) data.
Orange and blue bars represent the percentage of the stools positive or negative,
respectively for Campylobacter for a given kebele. C) Comparison of the
Campylobacter prevalence using conventional PCR (c-PCR) and meta-total RNA
sequencing (MeTRS). In red and blue are the stools positive or negative,
respectively for Campylobacter. The heat map is composed of 100 columns (one
column per child). Genus-specific PCR was performed using 16S RNA primers
and species-specific PCR for C. coli and C. jejuni were performed using ceuE and
mapA primers, respectively (Table S1).
Figure S3 | Co-occurrence of Campylobacter spp. in the children stool samples.
Co-occurrence Heatmap profile was created using the multivariate analysis data
(r2) based on the prevalence of Campylobacter spp. in the stool samples (see
Figure 2).
Figure S4 | Campylobacter spp. profile between children stool samples based on
the meta-total RNA sequencing (MeTRS). (A) Principal component analysis of the
Campylobacter spp. diversity and abundance in the stools. Each colored dot
represents one child stool sample (n = 100). Black dot represents the average
profile for a given kebele (n = 5). (B) Discriminant analysis of the Campylobacter
spp. diversity and abundance in the stools based on kebeles. The outside ellipse
contains ∼50% of the observations. The inside ellipse represents 95% confidence
level (Cut-off for MeTRS data; contigs number ≥ 10; Read length ≥ 50; Z-score ≥
1. (C). Clusterization profile of the stools based on the Campylobacter spp.
diversity, prevalence, and abundance data.
Figure S5 | Differences in abundance of Campylobacter hyointestinalis and
Campylobacter RM12175 between kebeles. Letters (A,B) indicates different
statistical groups (P < 0.01). Star: read per million (rpm) are significantly higher in
the designated kebele compared to the other kebeles.
Figure S6 | Campylobacter spp. profiles between children stool samples based
EED severity and diarrhea. Discriminant analysis of the Campylobacter spp.
abundance in the children stools based on (A) the gut permeability (lactulose%),
(C) gut inflammation ([myeloperoxidase] in ng/ml), (E) EED severity, and (G)
diarrhea prevalence data. The outside ellipse contains approximately 50% of the
observations. The inside ellipse represents 95% confidence level. Clusterization
profile of the Campylobacter spp. abundance in the stools based on (B) the gut
permeability (lactulose%), (D) gut inflammation ([myeloperoxidase] in ng/ml), (F)
EED severity, and (H) diarrhea prevalence data. Additional details concerning the
EED severity determination are presented in Table S1.
Figure S7 | Microbiome profiles between children stool samples based on
kebeles. (A) Principal component analysis of the children stool samples based on
kebeles. Each colored dot represents one stool sample (n = 100). Kebeles with
the same color code belong to the same cluster and therefore harbored equivalent
microbiota diversity and abundance. A T2 test revealed a total of 11 outliers
(stools with significantly different microbiota profile compared to the rest of the
population; outside the red oval). (B) Discriminant analysis of the stool microbiome
based on kebeles. The outside ellipse contains ∼50% of the observations. The
inside ellipse represents 95% confidence level. (C) Clusterization profile of the
stool microbiome based on kebeles.
Figure S8 | Microbiome profile based on Campylobacter prevalence. (A)
Discriminant analysis of the children stool microbiome based on Campylobacter
prevalence. The outside ellipse contains ∼50% of the observations. The inside
ellipse represents 95% confidence level. (B) Clusterization profile of the stool’s
microbiome based on Campylobacter prevalence.
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Figure S9 | Microbiome profile based on environmental enteric dysfunction (EED).
Discriminant analysis of the children stool microbiome composition based on (A)
the gut permeability (lactulose%), (C) gut inflammation ([MPO] in ng/ml), (E) EED
severity, and (G) diarrhea prevalence data. The outside ellipse contains ∼50% of
the observations. The inside ellipse represents 95% confidence level.
Clusterization profile of the Campylobacter spp. abundance in the stools based on
(B) the gut permeability (lactulose%), (D) gut inflammation ([MPO] in ng/ml), (F)
EED severity, and (H) diarrhea prevalence data. Additional details concerning the
EED severity determination are presented in Table S1. (I) Correlation between the
specific bacterial species of the children stool microbiome and the gut permeability
(lactulose%), gut inflammation ([MPO] in ng/ml), EED severity, and diarrhea
prevalence data. N, number of stools positive for the designated bacterium. Values
in the table represent the mean (log [read per million]) ± standard error for the
designated bacterial species for a given status. Stars represent bacterial species
harboring at least 2-fold difference in abundance between the “normal” and
“severe” status for at least one of the parameters studied. MPO: myeloperoxidase.
Table S1 | Primers used in the study. Source: Adapted from Deals et al. (28).
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